Regulation of Different IT on Vascular Function of Overweight Female University Students

October 24, 2024 updated by: Beijing Sport University

Regulation of Different Types of Interval Training on Vascular Function of Overweight Female University Students

This study investigates the effects of different interval training methods, specifically high-intensity interval training (HIIT) and sprint interval training (SIT), on vascular function in overweight female university students. A randomized controlled trial was conducted over an 8-week period.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This study aimed to evaluate how different types of interval training (HIIT and SIT) influence vascular function in overweight female university students. Participants were initially enrolled and randomly assigned to HIIT, SIT, or control groups. The participants in HIIT and SIT groups underwent an 8-week supervised exercise program 3 times per week on a treadmill. Both pre- and post-intervention measurements were taken, including vascular function, morphological indicators, and blood markers. This study highlights the potential of interval training as a time-efficient and effective intervention for improving cardiovascular health and body composition in this population.

Study Type

Interventional

Enrollment (Actual)

26

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • China
      • Beijing, China
        • School of Sports Medicine and Rehabilitation, Beijing Sport University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Participants aged between 18 and 25 years, female.
  • Participants' BMI more than 24 kg·m-2.
  • Participants without regular exercise habits.

Exclusion Criteria:

  • Participants underwent other interventions (e.g., nutrition, psychology, exercise, health education, et al).
  • Participants had a history of systematic and professional exercise habit.
  • Participants presenced of disease or condition restricting participation, such as injuries, respiratory disease or cardiovascular diseases.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control group
Experimental: HIIT group
Behavioral: HIIT
High-intensity interval training
Experimental: SIT group
Behavioral: SIT
Sprint interval training

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Brachial-ankle pulse wave velocity (baPWV)
Time Frame: 8 weeks
The change of baPWV before and after intervention.
8 weeks
Ankle-brachial index (ABI)
Time Frame: 8 weeks
The change of ABI before and after intervention.
8 weeks
Nitric oxide (NO)
Time Frame: 8 weeks
The change of NO before and after intervention.
8 weeks
Endothelin (ET)
Time Frame: 8 weeks
The change of ET before and after intervention.
8 weeks
Body weight (BW)
Time Frame: 8 weeks
The change of BW before and after intervention.
8 weeks
Body mass index (BMI)
Time Frame: 8 weeks
The change of BMI before and after intervention.
8 weeks
Body fat% (BF%)
Time Frame: 8 weeks
The change of BF% before and after intervention.
8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Height
Time Frame: 8 weeks
The change of height before and after intervention.
8 weeks
Blood pressure (BP)
Time Frame: 8 weeks
The change of BP before and after intervention.
8 weeks
Maximal oxygen uptake (VO2max)
Time Frame: 8 weeks
The change of VO2max before and after intervention.
8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Beijing Sport University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 15, 2021

Primary Completion (Actual)

September 30, 2021

Study Completion (Actual)

December 30, 2021

Study Registration Dates

First Submitted

October 24, 2024

First Submitted That Met QC Criteria

October 24, 2024

First Posted (Actual)

October 26, 2024

Study Record Updates

Last Update Posted (Actual)

October 26, 2024

Last Update Submitted That Met QC Criteria

October 24, 2024

Last Verified

October 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • RODTOITOVFOOFUS

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Overweight

Clinical Trials on HIIT

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hong Kong

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe